{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:58:17Z","timestamp":1793350697313,"version":"4.5.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T00:00:00Z","timestamp":1268265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>While the causes of multiple sclerosis (MS) are unknown, there is strong evidence that infection with Epstein\u2013Barr virus (EBV) is an important factor. In this review, we discuss the epidemiological evidence and argue for a causal role of EBV in MS aetiology. One of the most striking and consistent observations is that MS is extremely rare among EBV-negative individuals. Further, the timing of EBV infection appears to be critical, with individuals who are infected during adolescence and young adulthood, when the infection is more likely to manifest as mononucleosis, having a two- to threefold greater risk of MS compared to individuals infected in early life. These observations challenge the hygiene hypothesis which states that being in a high hygiene environment in early life increases future risk of MS \u2013 if this general formulation were true, EBV-negative individuals would be expected to have an increased risk of MS. Additional support for the causal role of EBV comes from longitudinal, prospective studies which show remarkable consistency, in that antibodies against EBV are elevated prior to MS onset. However, while infection with EBV is consistent with many observations of MS epidemiology, there are some that remain unexplained, suggesting that other factors are also involved in determining risk.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04121.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T10:06:47Z","timestamp":1280225207000},"page":"120-124","source":"Crossref","is-referenced-by-count":57,"title":["99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Epstein\u2013Barr virus and multiple sclerosis: epidemiological evidence"],"prefix":"10.1093","volume":"160","author":[{"given":"A","family":"Ascherio","sequence":"first","affiliation":[{"name":"Harvard School of Public Health, 655 Huntington Avenue, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K L","family":"Munger","sequence":"additional","affiliation":[{"name":"Harvard School of Public Health, 655 Huntington Avenue, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"2021122708515602300_b1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0404.1988.tb03672.x","article-title":"Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948\u201364 based on the Danish Multiple Sclerosis Registry","volume":"78","author":"Koch-Henriksen","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"2021122708515602300_b2","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.53.8.1711","article-title":"Geographic variation of MS incidence in two prospective studies of US women","volume":"53","author":"Hern\u00e1n","year":"1999","journal-title":"Neurology"},{"key":"2021122708515602300_b3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0404.1995.tb05853.x","article-title":"MS epidemiology world wide. One view of current status","volume":"161","author":"Kurtzke","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"2021122708515602300_b4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0303-8467(02)00036-7","article-title":"The worldwide prevalence of multiple sclerosis","volume":"104","author":"Pugliatti","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"2021122708515602300_b5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0301-0082(95)80008-V","article-title":"Migrant studies in multiple sclerosis","volume":"47","author":"Gale","year":"1995","journal-title":"Prog Neurobiol"},{"key":"2021122708515602300_b6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.35.5.672","article-title":"Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS","volume":"35","author":"Kurtzke","year":"1985","journal-title":"Neurology"},{"key":"2021122708515602300_b7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"2021122708515602300_b8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(63)90624-X","article-title":"Multiple sclerosis and poliomyelitis","volume":"2","author":"Poskanzer","year":"1963","journal-title":"Lancet"},{"key":"2021122708515602300_b9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04139.x","article-title":"The \u2018hygiene hypothesis\u2019 for autoimmune and allergic diseases: an update","volume":"160","author":"Okada","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021122708515602300_b10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.29.1.60","article-title":"Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation","volume":"29","author":"Leibowitz","year":"1966","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021122708515602300_b11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","article-title":"The effect of infections on susceptibility to autoimmune and allergic diseases","volume":"347","author":"Bach","year":"2002","journal-title":"N Engl J Med"},{"key":"2021122708515602300_b12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI8193","article-title":"The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis [Comment]","volume":"104","author":"Hafler","year":"1999","journal-title":"J Clin Invest"},{"key":"2021122708515602300_b13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.55.2.164","article-title":"Ubiquitous pathogens: links between infection and autoimmunity in MS? [Editorial; Comment]","volume":"55","author":"Hunter","year":"2000","journal-title":"Neurology"},{"key":"2021122708515602300_b14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.17.1.1","article-title":"Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the Army experience in World War II","volume":"17","author":"Beebe","year":"1967","journal-title":"Neurology"},{"key":"2021122708515602300_b15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1212\/WNL.48.1.204","article-title":"Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS","volume":"48","author":"Kurtzke","year":"1997","journal-title":"Neurology"},{"key":"2021122708515602300_b16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(71)90216-9","article-title":"Multiple sclerosis: occupation and social group at onset","volume":"2","author":"Russell","year":"1971","journal-title":"Lancet"},{"issue":"2","key":"2021122708515602300_b17","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1212\/WNL.49.2_Suppl_2.S42","article-title":"Part III: selected reviews. Common childhood and adolescent infections and multiple sclerosis","volume":"49","author":"Granieri","year":"1997","journal-title":"Neurology"},{"key":"2021122708515602300_b18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jama.293.4.463","article-title":"Exposure to infant siblings during early life and risk of multiple sclerosis","volume":"293","author":"Ponsonby","year":"2005","journal-title":"JAMA"},{"key":"2021122708515602300_b19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.10788","article-title":"Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography","volume":"55","author":"Wallin","year":"2004","journal-title":"Ann Neurol"},{"key":"2021122708515602300_b20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-642-67236-1_4","article-title":"4. Seroepidemiology of the virus","volume-title":"The Epstein\u2013Barr virus","author":"Henle","year":"1979"},{"key":"2021122708515602300_b21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann Neurol"},{"key":"2021122708515602300_b22","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.291.15.1875","article-title":"Epstein\u2013Barr virus in pediatric multiple sclerosis","volume":"291","author":"Alotaibi","year":"2004","journal-title":"JAMA"},{"key":"2021122708515602300_b23","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","article-title":"High seroprevalence of Epstein\u2013Barr virus in children with multiple sclerosis","volume":"67","author":"Pohl","year":"2006","journal-title":"Neurology"},{"key":"2021122708515602300_b24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","article-title":"Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study","volume":"6","author":"Banwell","year":"2007","journal-title":"Lancet Neurol"},{"key":"2021122708515602300_b25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneur.64.1.72","article-title":"Multiple sclerosis after infectious mononucleosis","volume":"64","author":"Nielsen","year":"2007","journal-title":"Arch Neurol"},{"key":"2021122708515602300_b26","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein\u2013Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"2021122708515602300_b27","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein\u2013Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstrom","year":"2004","journal-title":"Neurology"},{"key":"2021122708515602300_b28","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein\u2013Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"2021122708515602300_b29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","article-title":"Epstein\u2013Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up","volume":"63","author":"DeLorenze","year":"2006","journal-title":"Arch Neurol"},{"key":"2021122708515602300_b30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","article-title":"Integrating risk factors: HLA-DRB1*1501 and Epstein\u2013Barr virus in multiple sclerosis","volume":"70","author":"De Jager","year":"2008","journal-title":"Neurology"},{"key":"2021122708515602300_b31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/01.wnl.0000316195.52001.e1","article-title":"Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults","volume":"71","author":"Wang","year":"2008","journal-title":"Neurology"},{"key":"2021122708515602300_b32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(81)91527-0","article-title":"Multiple sclerosis and Epstein\u2013Barr virus (Letter)","volume":"2","author":"Warner","year":"1981","journal-title":"Lancet"},{"key":"2021122708515602300_b33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"2021122708515602300_b34","doi-asserted-by":"crossref","first-page":"1678S","DOI":"10.1093\/ajcn\/80.6.1678S","article-title":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease","volume":"80","author":"Holick","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"2021122708515602300_b35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-230X(08)60714-9","article-title":"Molecular epidemiology of Epstein\u2013Barr virus infection","volume":"67","author":"Gratama","year":"1995","journal-title":"Adv Cancer Res"},{"key":"2021122708515602300_b36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.1998.tb07320.x","article-title":"A single subtype of Epstein\u2013Barr virus in members of multiple sclerosis clusters","volume":"98","author":"Munch","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"2021122708515602300_b37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/jnnp.57.8.975","article-title":"Absence of Epstein\u2013Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation","volume":"57","author":"Hilton","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021122708515602300_b38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/13550289609146888","article-title":"Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction","volume":"2","author":"Sanders","year":"1996","journal-title":"Neurovirology"},{"key":"2021122708515602300_b39","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein\u2013Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"2021122708515602300_b40","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein\u2013Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis","year":"2009","journal-title":"Brain"},{"key":"2021122708515602300_b41","first-page":"115","article-title":"Does Epstein\u2013Barr virus cause multiple sclerosis?","volume":"1","author":"Cook","year":"2004","journal-title":"Rev Neurol Dis"},{"key":"2021122708515602300_b42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122708515602300_b43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ni835","article-title":"A functional and structural basis for TCR cross-reactivity in multiple sclerosis","volume":"3","author":"Lang","year":"2002","journal-title":"Nat Immunol"},{"key":"2021122708515602300_b44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2249.2003.02114.x","article-title":"Altered CD8+T cell responses to selected Epstein\u2013Barr virus immunodominant epitopes in patients with multiple sclerosis","volume":"132","author":"Hollsberg","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2021122708515602300_b45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/13550280490261671","article-title":"Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein\u2013Barr virus-transformed B cells","volume":"10","author":"Holmoy","year":"2004","journal-title":"J Neurovirol"},{"key":"2021122708515602300_b46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-510X(99)00298-1","article-title":"Epstein\u2013Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis","volume":"173","author":"Rand","year":"2000","journal-title":"J Neurol Sci"},{"key":"2021122708515602300_b47","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awl067","article-title":"Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis","volume":"129","author":"Lunemann","year":"2006","journal-title":"Brain"},{"key":"2021122708515602300_b48","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI200523661","article-title":"Identification of Epstein\u2013Barr virus proteins as putative targets of the immune response in multiple sclerosis","volume":"115","author":"Cepok","year":"2005","journal-title":"J Clin Invest"},{"key":"2021122708515602300_b49","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-{gamma} and IL-2","volume":"205","author":"Lunemann","year":"2008","journal-title":"J Exp Med"},{"key":"2021122708515602300_b50","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.184.3.971","article-title":"An Epstein\u2013Barr virus-associated superantigen","volume":"184","author":"Sutkowski","year":"1996","journal-title":"J Exp Med"},{"key":"2021122708515602300_b51","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1352458508094641","article-title":"Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis","volume":"14","author":"Tai","year":"2008","journal-title":"Mult Scler"},{"key":"2021122708515602300_b52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.162.1.129","article-title":"EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis","volume":"162","author":"Van Sechel","year":"1999","journal-title":"J Immunol"},{"key":"2021122708515602300_b53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature05935","article-title":"Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination","volume":"448","author":"Ousman","year":"2007","journal-title":"Nature"},{"key":"2021122708515602300_b54","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","article-title":"Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases","volume":"24","author":"Pender","year":"2003","journal-title":"Trends Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04121.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/160\/1\/120\/41924672\/j.1365-2249.2010.04121.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/160\/1\/120\/41924672\/j.1365-2249.2010.04121.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:39:51Z","timestamp":1685702391000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/160\/1\/120\/6429059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,3,11]]},"published-print":{"date-parts":[[2010,3,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04121.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,4]]},"published":{"date-parts":[[2010,3,11]]}}}